Abdi İbrahim Signs Agreement with Japan's Rohto for Innovative Eye Health Products

Abdi İbrahim has entered into a strategic partnership with Rohto Pharmaceutical Co., Ltd., a long-established Japanese pharmaceutical company. Under this agreement, the company will introduce Rohto's innovative eye health product to patients in Turkey under the Abdi İbrahim brand as of February 2025.

Abdi İbrahim, which has been operating for 113 years with a mission to improve life and the future, is adding another international partnership to its track record in the pharmaceutical sector. Having signed an agreement with Rohto, a Japanese brand that leads globally in over-the-counter pharmaceuticals, Abdi İbrahim will launch Rohto Dry Aid, a breakthrough eye drop product, in February 2025. Developed using Tearshield Technology to restore the natural tear film, this product offers an innovative and advanced approach to eye health, distinguishing it from conventional eye drops.

Abdi İbrahim CEO Süha Taşpolatoğlu, commenting on the agreement, stated: "As Abdi İbrahim, with our 113-year-old heritage, we continue our leading position in the Turkish pharmaceutical sector. This leadership draws strength from our vision of establishing innovative and exemplary partnerships not only within Turkey's borders but on a global scale. This agreement with Rohto is deeply meaningful as it represents the convergence of two long-established companies' missions to contribute to people and society.

Rohto's 126 years of innovation heritage and advanced technological capabilities, combined with Abdi İbrahim's commitment to sectoral leadership, will enable us to provide patients in Turkey with the most innovative and advanced eye health solutions. Eye health and consumer health represent two of the most strategically important areas we have focused on in recent years. This partnership is a strong indicator of our vision in these fields.

Furthermore, I believe this cooperation with Rohto is an important step in raising international standards in the Turkish pharmaceutical sector. While this partnership will deliver innovative solutions to patients in the Turkish market, it will also strengthen Abdi İbrahim's competitive power in the global sector. Following our strategic partnership with Otsuka of Japan in 2012, this cooperation with another Japanese company represents a new step that will contribute to deepening commercial and cultural ties between our two countries," he said.

Koji Suzuki, Director of the International Business Development Division at Rohto Pharmaceutical Co., Ltd., stated that he was honoured to enter into this strategic partnership with Abdi İbrahim, a leader in the Turkish pharmaceutical sector with an impressive heritage. Suzuki continued his remarks as follows: "This cooperation represents an important step forward in our shared mission to improve global health and well-being. By combining Rohto's more than 100 years of innovative approach in eye health with Abdi İbrahim's unique network and expertise, we aim to provide patients in Turkey with high-quality solutions. Developed through years of dedicated research,

Rohto's eye drops deliver effective
formulations, a pleasant user experience and highly functional packaging. Rohto Dry Aid represents the integration of our technology in a portfolio of many products we have. These unique features enable us to add value to the market and better meet consumers' changing needs. In 2024, Turkey and Japan celebrated the 100th anniversary of the establishment of diplomatic relations. As we enter a new century, we at Rohto Pharmaceutical are pleased to contribute to further deepening the commercial and cultural ties between our two countries."

An inspiring story from Rohto
This year marks the 126th anniversary of Rohto Pharmaceutical Co., Ltd., a company exemplifying a rich history and forward-thinking vision. Founded in the OTC category in 1899, Rohto has become a global leader in eye care, dermatology, skincare and advanced regenerative medicine. Rohto Pharmaceutical has maintained its market leadership in Japan's OTC eye drops market for 28 consecutive years.
The company's new slogan, "Moving the Heart," reflects a vision that transcends products, touching lives and promoting health and happiness. Rohto's 2030 vision, "Connect for Well-being," embraces the goal of providing a better life for everyone through health, improving physical, mental, social and environmental well-being, and bringing smiles to people everywhere.